VSIR and B-cell acute lymphoblastic leukemia: Our study highlights the role of VISTA as an important immune checkpoint in B-cell acute lymphoblastic leukemia (B-ALL), demonstrating its overexpression on CD8 + T cells and CD19 + B cells, which contributes to immune suppression and tumor evasion.